Two Sigma Advisers’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
295,800
+171,700
| +138% | +$1.4M | ﹤0.01% | 1028 |
|
|
2025
Q1 | $974K | Buy |
124,100
+65,300
| +111% | +$513K | ﹤0.01% | 1484 |
|
|
2024
Q4 | $876K | Buy |
58,800
+15,500
| +36% | +$231K | ﹤0.01% | 1526 |
|
|
2024
Q3 | $662K | Buy |
43,300
+5,200
| +14% | +$79.5K | ﹤0.01% | 1594 |
|
|
2024
Q2 | $580K | Sell |
38,100
-12,700
| -25% | -$193K | ﹤0.01% | 1815 |
|
|
2024
Q1 | $959K | Buy |
50,800
+17,200
| +51% | +$325K | ﹤0.01% | 1598 |
|
|
2023
Q4 | $642K | Sell |
33,600
-2,700
| -7% | -$51.6K | ﹤0.01% | 1823 |
|
|
2023
Q3 | $652K | Sell |
36,300
-1,300
| -3% | -$23.3K | ﹤0.01% | 1694 |
|
|
2023
Q2 | $764K | Sell |
37,600
-77,800
| -67% | -$1.58M | ﹤0.01% | 1646 |
|
|
2023
Q1 | $2.1M | Sell |
115,400
-56,900
| -33% | -$1.04M | 0.01% | 1249 |
|
|
2022
Q4 | $3.56M | Sell |
172,300
-2,500
| -1% | -$51.7K | 0.01% | 924 |
|
|
2022
Q3 | $4.57M | Buy |
174,800
+40,900
| +31% | +$1.07M | 0.01% | 775 |
|
|
2022
Q2 | $3.39M | Sell |
133,900
-20,900
| -14% | -$530K | 0.01% | 939 |
|
|
2022
Q1 | $4.89M | Sell |
154,800
-121,200
| -44% | -$3.82M | 0.01% | 807 |
|
|
2021
Q4 | $11.2M | Sell |
276,000
-15,300
| -5% | -$619K | 0.03% | 472 |
|
|
2021
Q3 | $10.2M | Sell |
291,300
-85,200
| -23% | -$2.97M | 0.03% | 514 |
|
|
2021
Q2 | $10.3M | Sell |
376,500
-89,900
| -19% | -$2.47M | 0.03% | 549 |
|
|
2021
Q1 | $13.1M | Sell |
466,400
-24,700
| -5% | -$694K | 0.04% | 476 |
|
|
2020
Q4 | $12.7M | Sell |
491,100
-55,500
| -10% | -$1.44M | 0.03% | 485 |
|
|
2020
Q3 | $9.37M | Buy |
546,600
+294,500
| +117% | +$5.05M | 0.03% | 552 |
|
|
2020
Q2 | $6.24M | Buy |
252,100
+177,900
| +240% | +$4.4M | 0.02% | 719 |
|
|
2020
Q1 | $1.03M | Buy |
74,200
+900
| +1% | +$12.5K | ﹤0.01% | 1474 |
|
|
2019
Q4 | $740K | Buy |
+73,300
| New | +$740K | ﹤0.01% | 1699 |
|